Century Therapeutics (IPSC) FCF Margin (2022 - 2025)
Century Therapeutics (IPSC) posted quarterly FCF Margin of 32.15% for Q1 2025, up 356867.0% year-over-year from N/an in Q1 2024, and up 94.46% quarter-over-quarter from 580.47% in Q4 2024.
Century Therapeutics (IPSC) FCF Margin (2022 - 2025) Analysis & Trends
Century Therapeutics (IPSC) has reported FCF Margin for 4 consecutive years, with 32.15% the latest figure, recorded in Q1 2025.
- In Q1 2025, FCF Margin rose 356867.0% year-over-year to 32.15%; the TTM figure through Dec 2025 stood at 95.95% (up 158749.0% YoY), while the FY2025 annual figure was 95.95%, up 157788.0% from the prior year.
- FCF Margin rose to 32.15% in Q1 2025 per IPSC's latest filing, from 580.47% in the prior quarter.
- Across five years, FCF Margin topped out at 7815.31% in Q1 2022 and bottomed at 23989.9% in Q2 2023.
- Historically, FCF Margin has averaged 4266.57% across 4 years, with a median of 2579.73% in 2022.
- Annual changes were most pronounced in 2023 — FCF Margin sank 2141017 bps — and 2024, when it surged 2041052 bps.
- Century Therapeutics' FCF Margin stood at 235.12% in 2022, then tumbled by 4218 bps to 10152.99% in 2023, then soared by 94 bps to 580.47% in 2024, then surged by 94 bps to 32.15% in 2025.
- Business Quant data shows IPSC's FCF Margin at 32.15% in Q1 2025, 580.47% in Q4 2024, and 3581.8% in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -77,594.17% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 70.82% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.62% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -22.35% |
| 10 | Century Therapeutics | 346.65 Mn | 86.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -32.15% |
| Dec 31, 2024 | -580.47% |
| Sep 30, 2024 | -3,581.80% |
| Jun 30, 2024 | -3,579.38% |
| Mar 31, 2024 | -3,600.82% |
| Dec 31, 2023 | -10,152.99% |
| Sep 30, 2023 | -11,428.38% |
| Jun 30, 2023 | -23,989.90% |
| Mar 31, 2023 | -1,988.95% |
| Dec 31, 2022 | -235.12% |
| Sep 30, 2022 | -1,531.03% |
| Jun 30, 2022 | -2,579.73% |
| Mar 31, 2022 | 7,815.31% |